A metabolic protective strategy could improve long-term survival in patients with LV-dysfunction undergoing CABG.

about

Post hoc analysis of the glutamics-trial: intravenous glutamate infusion and use of inotropic drugs after cabg.Central venous oxygen saturation during cardiopulmonary bypass predicts 3-year survival.Metabolic therapy in cardiac surgery--"Optimizing the engine's fuel supply and more...".

P2860

Q36092912-617C4E9E-5741-4026-A3F6-7537FB57C921 Q36470541-F49F6BBB-8E77-47AF-99DC-AE492CFE5C6C Q43169008-27B7643D-E57F-4F7D-B7D4-2AA04A8E864C

P2860

A metabolic protective strategy could improve long-term survival in patients with LV-dysfunction undergoing CABG.

Item

http://www.wikidata.org/entity/Q43169006

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

A metabolic protective strateg ...... V-dysfunction undergoing CABG.

@en

A metabolic protective strateg ...... V-dysfunction undergoing CABG.

@nl

type

Item

label

A metabolic protective strateg ...... V-dysfunction undergoing CABG.

@en

A metabolic protective strateg ...... V-dysfunction undergoing CABG.

@nl

prefLabel

A metabolic protective strateg ...... V-dysfunction undergoing CABG.

@en

A metabolic protective strateg ...... V-dysfunction undergoing CABG.

@nl

P1476

A metabolic protective strateg ...... V-dysfunction undergoing CABG.

@en

P2093

Erik Håkanson

http://www.w3.org/2001/XMLSchema#string

Ingemar Vanhanen

http://www.w3.org/2001/XMLSchema#string

Mårten Vidlund

http://www.w3.org/2001/XMLSchema#string

Rolf Svedjeholm

http://www.w3.org/2001/XMLSchema#string

P2860

Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery -- a systematic literature review.

Predicting survival after coronary revascularization for ischemic cardiomyopathy.

Coronary artery bypass grafting in patients with severe left ventricular dysfunction--early and mid-term outcomes.

Predicting long-term functional results after myocardial revascularization in ischemic cardiomyopathy.

Coronary surgery with non-cardioplegic methods in patients with advanced left ventricular dysfunction: immediate and long term results.

Apoptosis: pathophysiology and therapeutic implications for the cardiac surgeon.

A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.

Survival after myocardial revascularization for ischemic cardiomyopathy: a prospective ten-year follow-up study.

Coronary artery bypass grafting in patients with advanced left ventricular dysfunction.

Prediction of outcome after revascularization in patients with poor left ventricular function.

P304

45-58

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/14017430903531008

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41415792

http://www.w3.org/2001/XMLSchema#string

P698

20141344

http://www.w3.org/2001/XMLSchema#string

P921

coronary artery bypass surgery

A metabolic protective strategy could improve long-term survival in patients with LV-dysfunction undergoing CABG.

about

P2860

P2860

A metabolic protective strategy could improve long-term survival in patients with LV-dysfunction undergoing CABG.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921